Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentral Hospital, Nancy, France
About this trial
This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.
Eligibility criteria
Qualifiers
Patients suspected to have a bone or soft-tissue tumor referred for imaging for initial tumors characterization and staging.
Disqualifiers
Pregnancy
Breast feeding patients
Renal insufficiency
Contra indications to MRI or CT
Trial design
Treatments tested in this trial
- MR imaging
Treatment groups
740 Participants
are divided into 2 treatment groupsSponsors and collaborators
Central Hospital, Nancy, France
Lead sponsor
Lorraine Cancer Institute - ICL
Collaborator
Emille Gallé Surgical Center - CCEG
Collaborator
Diagnostic and Interventional Adaptative Imaging Laboratory - IADI
Collaborator
Source ClinicalTrials.gov